Kodiak Capital Group commits to purchase common shares through deal
By Devika Patel
Knoxville, Tenn., Jan. 21 – Endonovo Therapeutics Inc. said it has arranged a $3 million equity purchase agreement with Kodiak Capital Group, LLC.
The investor has committed to purchase up to $3 million of the company’s common shares.
The biotechnology company is based in Los Angeles.
| Issuer: | Endonovo Therapeutics Inc.
|
| Issue: | Equity purchase agreement
|
| Amount: | $3 million
|
| Warrants: | No
|
| Investor: | Kodiak Capital Group, LLC
|
| Pricing date: | Jan. 21
|
| Stock symbol: | OTCBB: ENDV
|
| Stock price: | $1.25 at close Jan. 20
|
| Market capitalization: | $95.8 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
